Brexit and the Healthcare Industry – Implications for Pharma, Q1 2018

brexit-and-the-eu

It has been almost two years since the UK voted to leave the EU. Businesses were told a vote to leave the EU would drive the UK into a severe recession, yet markets are up. Negotiations are ongoing to determine the UK’s post-Brexit relationship with the EU.

This report provides an assessment of how the pharmaceutical industry expects Brexit to affect the healthcare sector, both within and outside of Britain. This study will be repeated at the end of Q2 this year, to gauge the changing sentiment towards Brexit from within the healthcare industry.

This report provides in-house analyst expertise on the results of a 10 minutes survey of 155 GlobalData Pharma clients and prospects which was fielded from April 9, 2018 to April 23, 2018. Participants answered questions about how they expected Brexit to affect the healthcare sector, both within and outside of the UK. Components of the slide deck include –

  • Factors to Impact Healthcare: key factors to impact the post-Brexit UK healthcare industry providing respondent mix by region and seniority level
  • Impact on Research and Manufacturing: key factors to impact healthcare research and manufacturing in the UK post-Brexit providing respondent mix by region and seniority level
  • Impact on Corporate Strategy: level of impact of Brexit on corporate strategy providing respondent mix by region, seniority level, and headquarter location
  • Impact on Relocation: impact of Brexit on staff and headquarter relocation as indicated by resondents whose headquarters is located in the UK

Reasons to buy

  • Develop and design your corporate strategies post-Brexit through an in-house expert analysis of the key factors to impact the post-Brexit UK healthcare industry.
  • Develop business strategies by understanding the key factors to impact healthcare research and manufacturing in the UK post-Brexit.
  • Stay up to date on the industry’s changing sentiment towards Brexit from within the healthcare industry with quarterly surveys.
  • Identify emerging industry trends post-Brexit to gain a competitive advantage.

 

Brexit and the Healthcare Industry – Implications for Pharma, Q1 2018

Report Information:
Single User License Price:
 $500
Published: 2018
Publisher: GlobalData
Report Format: electronic pdf

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s